Lawrence N. Marinucci

1.5k total citations
8 papers, 1.0k citations indexed

About

Lawrence N. Marinucci is a scholar working on Pathology and Forensic Medicine, Rheumatology and Hematology. According to data from OpenAlex, Lawrence N. Marinucci has authored 8 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 2 papers in Rheumatology and 2 papers in Hematology. Recurrent topics in Lawrence N. Marinucci's work include Multiple Sclerosis Research Studies (5 papers), Rheumatoid Arthritis Research and Therapies (2 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). Lawrence N. Marinucci is often cited by papers focused on Multiple Sclerosis Research Studies (5 papers), Rheumatoid Arthritis Research and Therapies (2 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). Lawrence N. Marinucci collaborates with scholars based in United States and Italy. Lawrence N. Marinucci's co-authors include Andrew Goodman, Andrew R. Blight, Ron Cohen, Lauren Krupp, Randall T. Schapiro, Theodore R. Brown, Steven R. Schwid, Keith R. Edwards, Craig I Coleman and Diana M Sobieraj and has published in prestigious journals such as The Lancet, Neurology and Annals of Neurology.

In The Last Decade

Lawrence N. Marinucci

8 papers receiving 948 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lawrence N. Marinucci United States 7 785 355 198 131 129 8 1.0k
N. Téllez Spain 11 752 1.0× 337 0.9× 172 0.9× 95 0.7× 88 0.7× 12 932
Pietro Annovazzi Italy 18 671 0.9× 359 1.0× 147 0.7× 60 0.5× 103 0.8× 46 964
Giacomo Lus Italy 19 555 0.7× 259 0.7× 57 0.3× 73 0.6× 184 1.4× 85 950
Beata Zakrzewska‐Pniewska Poland 12 494 0.6× 406 1.1× 57 0.3× 31 0.2× 100 0.8× 56 889
Laura Vacchi Italy 11 443 0.6× 136 0.4× 56 0.3× 45 0.3× 99 0.8× 18 724
Elisabeth Andreadou Greece 16 258 0.3× 503 1.4× 71 0.4× 32 0.2× 166 1.3× 60 1.1k
Cullen O’Gorman Australia 18 214 0.3× 405 1.1× 107 0.5× 19 0.1× 121 0.9× 40 882
O Lyon-Caen France 12 387 0.5× 187 0.5× 135 0.7× 52 0.4× 90 0.7× 35 835
Giorgio Giuliani Italy 14 307 0.4× 125 0.4× 83 0.4× 37 0.3× 56 0.4× 29 591
Johanna Krüger Finland 12 213 0.3× 190 0.5× 122 0.6× 22 0.2× 115 0.9× 48 664

Countries citing papers authored by Lawrence N. Marinucci

Since Specialization
Citations

This map shows the geographic impact of Lawrence N. Marinucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence N. Marinucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence N. Marinucci more than expected).

Fields of papers citing papers by Lawrence N. Marinucci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence N. Marinucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence N. Marinucci. The network helps show where Lawrence N. Marinucci may publish in the future.

Co-authorship network of co-authors of Lawrence N. Marinucci

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence N. Marinucci. A scholar is included among the top collaborators of Lawrence N. Marinucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence N. Marinucci. Lawrence N. Marinucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Marinucci, Lawrence N., et al.. (2020). Impact of OFF periods on aspects of employment for people with Parkinson's disease. Parkinsonism & Related Disorders. 79. e89–e89. 1 indexed citations
2.
Coleman, Craig I, Diana M Sobieraj, & Lawrence N. Marinucci. (2011). Minimally important clinical difference of the Timed 25-Foot Walk Test: results from a randomized controlled trial in patients with multiple sclerosis. Current Medical Research and Opinion. 28(1). 49–56. 77 indexed citations
3.
Goodman, Andrew, Theodore R. Brown, Keith R. Edwards, et al.. (2010). A phase 3 trial of extended release oral dalfampridine in multiple sclerosis. Annals of Neurology. 68(4). 494–502. 246 indexed citations
4.
Goodman, Andrew, Theodore R. Brown, Lauren Krupp, et al.. (2009). Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. The Lancet. 373(9665). 732–738. 380 indexed citations
6.
Goodman, Andrew, J. A. Cohen, Lauren Krupp, et al.. (2008). Dose comparison trial of sustained-release fampridine in multiple sclerosis. Neurology. 71(15). 1134–1141. 145 indexed citations
7.
Goodman, Andrew, Jeffrey A. Cohen, Anne H. Cross, et al.. (2007). Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study. Multiple Sclerosis Journal. 13(3). 357–368. 123 indexed citations
8.
Liew, Judith B. Van, Paul J. Davis, L. L. Bernardis, et al.. (1993). Effects of Aging, Diet, and Sex on Plasma Glucose, Fructosamine, and Lipid Concentrations in Barrier-Raised Fischer 344 Rats. Journal of Gerontology. 48(5). B184–B190. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026